Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

2.580
+0.0401.57%
Volume:315.89K
Turnover:845.11K
Market Cap:1.59B
PE:-7.10
High:2.700
Open:2.630
Low:2.580
Close:2.540
52wk High:6.150
52wk Low:2.380
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:2.47
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.363
ROE:-242.61%
ROA:-17.94%
PB:-9.88
PE(LYR):-7.10
PS:- -

Loading ...

IMMUNOTECH-B Finalizes Issuance of New Convertible Bonds and Notes

Deep News
·
Feb 16

China's Innovative Drug Sector Poised for Global Leap in 2026, Says Senrui Investment Chairman

Deep News
·
Feb 15

IMMUNOTECH-B Finalizes Issuance of New Convertible Bonds and Notes

Stock News
·
Feb 13

Immunotech Biopharm Ltd (6978) Completes RMB270.00 Million New Convertible Bonds Issue and Settles 2023 Convertible Bonds

Bulletin Express
·
Feb 13

Immunotech Biopharm Completes RMB300 Million Convertible Bond Issuance

Reuters
·
Feb 13

Pharmaceutical Firms Flock to Hong Kong for Listings in 2025

Deep News
·
Feb 13

Beijing Promotes Negotiated Pricing Between Insurers and Pharmaceutical Firms to Accelerate Commercial Health Insurance Drug Formulary Implementation

Deep News
·
Feb 12

Hengrui Pharma's Innovative Drug HRS-5346 for Elevated Lipoprotein(a) Levels Added to Breakthrough Therapy List

Deep News
·
Feb 12

HuaShang Fund's Sun Wei: China's Innovative Drug Sector Gains Global Prominence, May Drive Industry-Wide Recovery

Deep News
·
Feb 12

Guosen Securities Highlights Undervalued Healthcare Services and Consumer Sectors with Earnings Recovery Potential

Stock News
·
Feb 12

HuaShang Fund's Zhang Xiao: Clinical Data Narrative Replaces BD Storytelling, Driving Domestic Innovative Drug Development

Deep News
·
Feb 11

Hong Kong Stocks Lead Biotech Rebound as 520880 Surges Nearly 4% on Heavy Volume; Byte's Seedance2.0 Goes Viral; AI and Chip ETFs Rally

Deep News
·
Feb 10

Breakthroughs in Overseas Partnerships and Financial Performance Drive Hong Kong-Listed Innovative Drug Stocks' Rally, ETF 520880 Surges 3.86% on Heavy Volume

Deep News
·
Feb 10

Huasheng Fund Manager Liu Li Identifies Three Key Investment Sectors for 2026

Deep News
·
Feb 10

Biopharmaceutical Stocks Show Broad Gains with CSPC PHARMA Leading with Over 7% Rise

Deep News
·
Feb 10

CRO Stocks Lead Gains as Biopharma Investment and Cross-Border Deals Rebound

Stock News
·
Feb 10

IMMUNOTECH-B Plans Issuance of RMB270 Million New Convertible Bonds and RMB30 Million Notes

Stock News
·
Feb 09

Immunotech Biopharm (6978) Announces Proposed RMB300 Million Convertible Bonds Issue and Settlement of Existing Bonds

Bulletin Express
·
Feb 09

Immunotech Biopharm - to Issue Convertible Bonds Worth RMB270 Mln

THOMSON REUTERS
·
Feb 09

Immunotech Biopharm Announces New Convertible Bond Subscription Agreement

Reuters
·
Feb 09